These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17681355

  • 1. Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse.
    Kilb W, Sinning A, Luhmann HJ.
    Neuropharmacology; 2007 Sep; 53(4):524-33. PubMed ID: 17681355
    [Abstract] [Full Text] [Related]

  • 2. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
    Dzhala VI, Brumback AC, Staley KJ.
    Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
    [Abstract] [Full Text] [Related]

  • 3. Early developmental alterations of low-Mg2+ -induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro.
    Moser J, Kilb W, Werhahn KJ, Luhmann HJ.
    Brain Res; 2006 Mar 10; 1077(1):170-7. PubMed ID: 16510134
    [Abstract] [Full Text] [Related]

  • 4. Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus.
    Nardou R, Ben-Ari Y, Khalilov I.
    J Neurophysiol; 2009 Jun 10; 101(6):2878-88. PubMed ID: 19297515
    [Abstract] [Full Text] [Related]

  • 5. Propagation dynamics of epileptiform activity acutely induced by bicuculline in the hippocampal-parahippocampal region of the isolated Guinea pig brain.
    Uva L, Librizzi L, Wendling F, de Curtis M.
    Epilepsia; 2005 Dec 10; 46(12):1914-25. PubMed ID: 16393157
    [Abstract] [Full Text] [Related]

  • 6. Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons.
    Lappin SC, Dale TJ, Brown JT, Trezise DJ, Davies CH.
    Brain Res; 2005 Dec 14; 1065(1-2):37-46. PubMed ID: 16336949
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of cation-chloride co-transport-blocking diuretics in a rat hippocampal slice model of epilepsy.
    Margineanu DG, Klitgaard H.
    Epilepsy Res; 2006 May 14; 69(2):93-9. PubMed ID: 16495037
    [Abstract] [Full Text] [Related]

  • 8. Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE).
    Li X, Zhou J, Chen Z, Chen S, Zhu F, Zhou L.
    Brain Res; 2008 Jul 24; 1221():141-6. PubMed ID: 18550034
    [Abstract] [Full Text] [Related]

  • 9. Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital.
    Nardou R, Yamamoto S, Chazal G, Bhar A, Ferrand N, Dulac O, Ben-Ari Y, Khalilov I.
    Brain; 2011 Apr 24; 134(Pt 4):987-1002. PubMed ID: 21436113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
    Kahle KT, Staley KJ.
    Neurosurg Focus; 2008 Sep 24; 25(3):E22. PubMed ID: 18759624
    [Abstract] [Full Text] [Related]

  • 15. The influence of bumetanide on the membrane potential of mouse skeletal muscle cells in isotonic and hypertonic media.
    van Mil HG, Geukes Foppen RJ, Siegenbeek van Heukelom J.
    Br J Pharmacol; 1997 Jan 24; 120(1):39-44. PubMed ID: 9117096
    [Abstract] [Full Text] [Related]

  • 16. Inwardly rectifying K(+) (Kir) channels antagonize ictal-like epileptiform activity in area CA1 of the rat hippocampus.
    Andreasen M, Skov J, Nedergaard S.
    Hippocampus; 2007 Jan 24; 17(11):1037-48. PubMed ID: 17604346
    [Abstract] [Full Text] [Related]

  • 17. NKCC1 transporter facilitates seizures in the developing brain.
    Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ.
    Nat Med; 2005 Nov 24; 11(11):1205-13. PubMed ID: 16227993
    [Abstract] [Full Text] [Related]

  • 18. Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus.
    Sivakumaran S, Maguire J.
    Epilepsia; 2016 Feb 24; 57(2):222-32. PubMed ID: 26659482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.